{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T23:24:41Z","timestamp":1791501881333,"version":"4.3.4"},"reference-count":36,"publisher":"Elsevier BV","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.bbr.2013.06.017","type":"journal-article","created":{"date-parts":[[2013,6,25]],"date-time":"2013-06-25T09:51:00Z","timestamp":1372153860000},"page":"405-414","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Pharmacological disruption of mouse social approach behavior: Relevance to negative symptoms of schizophrenia"],"prefix":"10.1016","volume":"252","author":[{"given":"Ashley N.","family":"Hanks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Dlugolenski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zo\u00eb A.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia A.","family":"Seymour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Majchrzak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2013.06.017_bib0005","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0920-9964(03)00129-4","article-title":"Comparative effects of glycine and d-cycloserine on persistent negative symptoms in schizophrenia: a retrospective analysis","volume":"66","author":"Heresco-Levy","year":"2004","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.bbr.2013.06.017_bib0010","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s11920-010-0122-x","article-title":"Promise and pitfalls of animal models of schizophrenia","volume":"12","author":"Feifel","year":"2010","journal-title":"Current Psychiatry Reports"},{"key":"10.1016\/j.bbr.2013.06.017_bib0015","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1093\/schbul\/sbq106","article-title":"The role of rodent models in the discovery of new treatments for schizophrenia: updating our strategy","volume":"36","author":"Moore","year":"2010","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.bbr.2013.06.017_bib0020","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/nn.2647","article-title":"Animal models of neuropsychiatric disorders","volume":"13","author":"Nestler","year":"2010","journal-title":"Nature Neuroscience"},{"key":"10.1016\/j.bbr.2013.06.017_bib0025","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/00008877-200006000-00006","article-title":"Animal models for the negative symptoms of schizophrenia","volume":"11","author":"Ellenbroek","year":"2000","journal-title":"Behavioural Pharmacology"},{"key":"10.1016\/j.bbr.2013.06.017_bib0030","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/schbul\/sbp125","article-title":"Mutant mouse models: genotype\u2013phenotype relationships to negative symptoms in schizophrenia","volume":"36","author":"O\u2019Tuathaigh","year":"2010","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.bbr.2013.06.017_bib0035","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0014-2999(03)01273-1","article-title":"A review of 25 years of the social interaction test","volume":"463","author":"File","year":"2003","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.bbr.2013.06.017_bib0040","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.brainres.2003.12.013","article-title":"Social approach \u2013 avoidance behavior of inbred mouse strains towards DBA\/2 mice","volume":"1002","author":"Brodkin","year":"2004","journal-title":"Brain Research"},{"key":"10.1016\/j.bbr.2013.06.017_bib0045","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1601-183X.2004.00071.x","article-title":"Automated apparatus for quantitation of social approach behaviors in mice","volume":"3","author":"Nadler","year":"2004","journal-title":"Genes, Brain and Behavior"},{"key":"10.1016\/j.bbr.2013.06.017_bib0050","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bbr.2006.07.030","article-title":"Mouse behavioral tasks relevant to autism: phenotypes of 10 inbred strains","volume":"176","author":"Moy","year":"2007","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/j.bbr.2013.06.017_bib0055","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/2040-2392-2-7","article-title":"Histopathologic characterization of the BTBR mouse model of autistic-like behavior reveals selective changes in neurodevelopmental proteins and adult hippocampal neurogenesis","volume":"2","author":"Stephenson","year":"2011","journal-title":"Molecular Autism"},{"key":"10.1016\/j.bbr.2013.06.017_bib0060","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1126\/scitranslmed.3003501","article-title":"Negative Allosteric Modulation of the mGluR5 receptor reduces repetitive behaviors and rescues social deficits in mouse models of Autism","volume":"4","author":"Silverman","year":"2012","journal-title":"Science Translational Medicine"},{"key":"10.1016\/j.bbr.2013.06.017_bib0065","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1192\/bjp.181.4.271","article-title":"Dopamine and antipsychotic drug action revisited","volume":"181","author":"Jones","year":"2002","journal-title":"The British Journal of Psychiatry"},{"key":"10.1016\/j.bbr.2013.06.017_bib0070","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/syn.890010203","article-title":"Dopamine receptors and the dopamine hypothesis of schizophrenia","volume":"1","author":"Seeman","year":"1987","journal-title":"Synapse"},{"key":"10.1016\/j.bbr.2013.06.017_bib0075","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/npp.2011.181","article-title":"From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment","volume":"37","author":"Moghaddam","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2013.06.017_bib0080","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1146\/annurev.pharmtox.42.082701.160735","article-title":"Glutamatergic mechanisms in schizophrenia","volume":"42","author":"Tsai","year":"2002","journal-title":"Annual Review of Pharmacology and Toxicology"},{"key":"10.1016\/j.bbr.2013.06.017_bib0085","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0022-3956(99)00029-1","article-title":"NMDA receptor hypofunction model of schizophrenia","volume":"33","author":"Olney","year":"1999","journal-title":"Journal of Psychiatric Research"},{"key":"10.1016\/j.bbr.2013.06.017_bib0090","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0092-8674(00)81972-8","article-title":"Mice with reduced NMDA receptor expression display behaviors related to schizophrenia","volume":"98","author":"Mohn","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.bbr.2013.06.017_bib0095","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.bcp.2004.07.034","article-title":"The GABA-glutamate connection in schizophrenia: which is the proximate cause","volume":"68","author":"Coyle","year":"2004","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.bbr.2013.06.017_bib0100","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev.pharmtox.41.1.237","article-title":"Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence","volume":"41","author":"Carlsson","year":"2001","journal-title":"Annual Review of Pharmacology and Toxicology"},{"key":"10.1016\/j.bbr.2013.06.017_bib0105","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/01.jcp.0000095349.32154.a5","article-title":"GABA Schizophrenia: a review of basic science and clinical studies","volume":"23","author":"Wassef","year":"2003","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.bbr.2013.06.017_bib0110","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/aur.163","article-title":"Social peers rescue autism-relevant sociability deficits in adolescent mice","volume":"4","author":"Yang","year":"2011","journal-title":"Autism Research"},{"key":"10.1016\/j.bbr.2013.06.017_bib0115","doi-asserted-by":"crossref","DOI":"10.3389\/neuro.08.002.2009","article-title":"Effects of subchronic phencyclidine (PCP) treatment on social behaviors, and operant discrimination and reversal learning in C57BL\/6J mice","volume":"3","author":"Brigman","year":"2009","journal-title":"Frontiers in Behavioral Neuroscience"},{"key":"10.1016\/j.bbr.2013.06.017_bib0120","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000172620","article-title":"Effects of d-cycloserine administration on weekly nonemotional memory tasks in healthy participants","volume":"78","author":"Otto","year":"2009","journal-title":"Psychotherapy and Psychosomatics"},{"key":"10.1016\/j.bbr.2013.06.017_bib0125","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1601-183X.2007.00330.x","article-title":"Autism-like behavioral phenotypes in BTBR T+tf\/J mice","volume":"7","author":"McFarlane","year":"2008","journal-title":"Genes, Brain and Behavior"},{"key":"10.1016\/j.bbr.2013.06.017_bib0130","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1601-183X.2009.00504.x","article-title":"Assessment of NMDA receptor NR1 subunit hypofunction in mice as a model for schizophrenia","volume":"8","author":"Halene","year":"2009","journal-title":"Genes, Brain and Behavior"},{"key":"10.1016\/j.bbr.2013.06.017_bib0135","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00213-008-1196-6","article-title":"Mice with reduced NMDA receptor glycine affinity model some of the negative and cognitive symptoms of schizophrenia","volume":"200","author":"Labrie","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2013.06.017_bib0140","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.bbr.2009.02.007","article-title":"Evaluation of NMDA receptor models of schizophrenia: divergences in the behavioral effects of sub-chronic PCP and MK-801","volume":"204","author":"Seillier","year":"2009","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/j.bbr.2013.06.017_bib0145","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1124\/jpet.109.155994","article-title":"Phosphodiesterase 10A inhibitor activity in preclinical models of the positive, cognitive, and negative symptoms of schizophrenia","volume":"331","author":"Grauer","year":"2009","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.bbr.2013.06.017_bib0150","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ntt.2012.07.007","article-title":"Disruption of social approach by MK-801, amphetamine, and fluoxetine in adolescent C57BL\/6J mice","volume":"36","author":"Moy","year":"2013","journal-title":"Neurotoxicology and Teratology"},{"key":"10.1016\/j.bbr.2013.06.017_bib0155","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1038\/sj.npp.1300124","article-title":"Withdrawal from chronic phencyclidine treatment induces long-lasting depression in brain reward function","volume":"28","author":"Spielewoy","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2013.06.017_bib0160","series-title":"Evaluation of the effects of withdrawal from acute PCP on progressive ratio responding-relevance to negative symptoms of schizophrenia? program no. 924. 15. 2012 neuroscience meeting planner","author":"Dlugolenski","year":"2012"},{"key":"10.1016\/j.bbr.2013.06.017_bib0165","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.neulet.2009.10.091","article-title":"Neurochemical, behavioral and architectural changes after chronic inactivation of NMDA receptors in mice","volume":"468","author":"Elhardt","year":"2010","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.bbr.2013.06.017_bib0170","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.neuropharm.2012.07.042","article-title":"Influence of stimulant-induced hyperactivity on social approach in the BTBR mouse model of autism","volume":"68","author":"Silverman","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2013.06.017_bib0175","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1527-3458.2007.00025.x","article-title":"Pharmacology of the \u03b2-carboline FG-7142, a partial inverse agonist at the benzodiazepine allosteric site of the GABAA receptor: neurochemical, neurophysiological, and behavioral effects","volume":"13","author":"Evans","year":"2007","journal-title":"CNS Drug Reviews"},{"key":"10.1016\/j.bbr.2013.06.017_bib0180","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.pharmthera.2010.07.004","article-title":"Animal models of cognitive dysfunction and negative symptoms of schizophrenia: focus on NMDA receptor antagonism","volume":"128","author":"Neill","year":"2010","journal-title":"Pharmacology and Therapeutics"}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432813003628?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432813003628?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,16]],"date-time":"2019-07-16T03:27:50Z","timestamp":1563247670000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432813003628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":36,"alternative-id":["S0166432813003628"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2013.06.017","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological disruption of mouse social approach behavior: Relevance to negative symptoms of schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2013.06.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}